News Focus
News Focus
icon url

marzan

07/07/25 9:26 AM

#437200 RE: rosemountbomber #437199

Well, these hyenas are hunted down now, imo. Two violations: fraud in the court by cropping the table, and infringing into cardio label. They are caught now. Of course the PBMs are proactive now, imo, but may not be off the hook.
icon url

Number sleven

07/07/25 10:10 AM

#437204 RE: rosemountbomber #437199

RMB, If you want to get a better understanding of how Amarin v Hikma is going to play out, read all of the filings from GSK v Teva. We have the same legal representation. That case is a road map. Use a combination theory, label plus inappropriate advertising, to get past the pleading stage. Then go after the validity of the label through expert testimony during the trial. North is correct that the court could invalidate the "skinny label" on the basis of fraud. That issue has not yet been presented.
Sleven,